Want to join the conversation?
$MRK, which competes with rivals $GSK and $PFE, said the company's human health and animal health businesses performed well in 2Q16, delivering growth despite an approx. $210MM headwind in sales in Venezuela in 2Q15. The company said it expects adjusted OpEx for the full year to be generally in line with the prior year.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?